Drug Discovery for Parkinson's With Mutations in the GBA Gene
Part of paid clinical trials in New York, New York.
- Sponsor
- New York Stem Cell Foundation Research Institute
- Study ID
- NCT05536388
- Status
- Recruiting
Conditions
- GBA Gene Mutation
- Gaucher Disease
- Healthy
- Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Biological Sample Collection — OTHERSkin biopsy (2-3mm) and/or blood (up to 50 mL); saliva; excess/leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure)
Study Details
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.
Key Dates
- Start date
- Jul 15, 2022
- Status verified
- Jul 2024
- Primary completion
- Jul 15, 2025
- Completion
- Jul 15, 2025
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Parkinson's DiseaseSubjects in this group will have a diagnosis of Parkinson's disease with or without a known GBA gene mutation.
- Arm: Gaucher DiseaseSubjects in this group with have a diagnosis of Gaucher disease with or without a known GBA gene mutation.
- Arm: Healthy ControlSubjects in this group will serve as healthy controls.
Primary Outcome Measure
Establishment of a diverse bank of biological samples, stem cell lines, derivatives, and associated information. [ Time Frame: Baseline ]
Central Contacts
- Clinical Research Office212-927-1801
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The New York Stem Cell Foundation Research Institute | New York | New York | 10019 | Laura Andres-Martin (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By condition
By specialty
Related Studies
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Phoenix, Arizona
- Evaluation and Optimization of Ultrasound and/or MRI Hardware and SoftwareRecruiting · State University of New York - Upstate Medical University · Syracuse, New York
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated DonorsPHASE3 · Recruiting · Center for International Blood and Marrow Transplant Research · Boca Raton, Florida
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts